Request Free Sample ×
Japan Diagnostic Imaging Services Market Research Report-Forecast to 2035 Infographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Japan Diagnostic Imaging Services Market

ID: MRFR/HS/51819-HCR
200 Pages
Rahul Gotadki
Last Updated: February 06, 2026

Japan Diagnostic Imaging Services Market Research Report: Size, Share, Trend Analysis By Procedure Type (X-ray, Ultrasound, Magnetic Resonance Imaging, Computed Tomography, Nuclear Medicine), By End Users (Hospitals, Diagnostic Centers, Outpatient Imaging Centers, Research Laboratories), By Imaging Modality (Analog Imaging, Digital Imaging, Hybrid Imaging) and By Applications (Cardiology, Oncology, Neurology, Orthopedics) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Japan Diagnostic Imaging Services Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Life Sciences, BY Procedure Type (USD Billion)
  49.     4.1.1 X-ray
  50.     4.1.2 Ultrasound
  51.     4.1.3 Magnetic Resonance Imaging
  52.     4.1.4 Computed Tomography
  53.     4.1.5 Nuclear Medicine
  54.   4.2 Life Sciences, BY End User (USD Billion)
  55.     4.2.1 Hospitals
  56.     4.2.2 Diagnostic Centers
  57.     4.2.3 Outpatient Imaging Centers
  58.     4.2.4 Research Laboratories
  59.   4.3 Life Sciences, BY Imaging Modality (USD Billion)
  60.     4.3.1 Analog Imaging
  61.     4.3.2 Digital Imaging
  62.     4.3.3 Hybrid Imaging
  63.   4.4 Life Sciences, BY Application (USD Billion)
  64.     4.4.1 Cardiology
  65.     4.4.2 Oncology
  66.     4.4.3 Neurology
  67.     4.4.4 Orthopedics
  68. 5 SECTION V: COMPETITIVE ANALYSIS
  69.   5.1 Competitive Landscape
  70.     5.1.1 Overview
  71.     5.1.2 Competitive Analysis
  72.     5.1.3 Market share Analysis
  73.     5.1.4 Major Growth Strategy in the Life Sciences
  74.     5.1.5 Competitive Benchmarking
  75.     5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
  76.     5.1.7 Key developments and growth strategies
  77.       5.1.7.1 New Product Launch/Service Deployment
  78.       5.1.7.2 Merger & Acquisitions
  79.       5.1.7.3 Joint Ventures
  80.     5.1.8 Major Players Financial Matrix
  81.       5.1.8.1 Sales and Operating Income
  82.       5.1.8.2 Major Players R&D Expenditure. 2023
  83.   5.2 Company Profiles
  84.     5.2.1 Siemens Healthineers (DE)
  85.       5.2.1.1 Financial Overview
  86.       5.2.1.2 Products Offered
  87.       5.2.1.3 Key Developments
  88.       5.2.1.4 SWOT Analysis
  89.       5.2.1.5 Key Strategies
  90.     5.2.2 GE Healthcare (US)
  91.       5.2.2.1 Financial Overview
  92.       5.2.2.2 Products Offered
  93.       5.2.2.3 Key Developments
  94.       5.2.2.4 SWOT Analysis
  95.       5.2.2.5 Key Strategies
  96.     5.2.3 Philips Healthcare (NL)
  97.       5.2.3.1 Financial Overview
  98.       5.2.3.2 Products Offered
  99.       5.2.3.3 Key Developments
  100.       5.2.3.4 SWOT Analysis
  101.       5.2.3.5 Key Strategies
  102.     5.2.4 Canon Medical Systems (JP)
  103.       5.2.4.1 Financial Overview
  104.       5.2.4.2 Products Offered
  105.       5.2.4.3 Key Developments
  106.       5.2.4.4 SWOT Analysis
  107.       5.2.4.5 Key Strategies
  108.     5.2.5 Fujifilm Holdings (JP)
  109.       5.2.5.1 Financial Overview
  110.       5.2.5.2 Products Offered
  111.       5.2.5.3 Key Developments
  112.       5.2.5.4 SWOT Analysis
  113.       5.2.5.5 Key Strategies
  114.     5.2.6 Hitachi Medical Corporation (JP)
  115.       5.2.6.1 Financial Overview
  116.       5.2.6.2 Products Offered
  117.       5.2.6.3 Key Developments
  118.       5.2.6.4 SWOT Analysis
  119.       5.2.6.5 Key Strategies
  120.     5.2.7 Hologic (US)
  121.       5.2.7.1 Financial Overview
  122.       5.2.7.2 Products Offered
  123.       5.2.7.3 Key Developments
  124.       5.2.7.4 SWOT Analysis
  125.       5.2.7.5 Key Strategies
  126.     5.2.8 Agfa-Gevaert Group (BE)
  127.       5.2.8.1 Financial Overview
  128.       5.2.8.2 Products Offered
  129.       5.2.8.3 Key Developments
  130.       5.2.8.4 SWOT Analysis
  131.       5.2.8.5 Key Strategies
  132.     5.2.9 Radiology Partners (US)
  133.       5.2.9.1 Financial Overview
  134.       5.2.9.2 Products Offered
  135.       5.2.9.3 Key Developments
  136.       5.2.9.4 SWOT Analysis
  137.       5.2.9.5 Key Strategies
  138.   5.3 Appendix
  139.     5.3.1 References
  140.     5.3.2 Related Reports
  141. 6 LIST OF FIGURES
  142.   6.1 MARKET SYNOPSIS
  143.   6.2 JAPAN MARKET ANALYSIS BY PROCEDURE TYPE
  144.   6.3 JAPAN MARKET ANALYSIS BY END USER
  145.   6.4 JAPAN MARKET ANALYSIS BY IMAGING MODALITY
  146.   6.5 JAPAN MARKET ANALYSIS BY APPLICATION
  147.   6.6 KEY BUYING CRITERIA OF LIFE SCIENCES
  148.   6.7 RESEARCH PROCESS OF MRFR
  149.   6.8 DRO ANALYSIS OF LIFE SCIENCES
  150.   6.9 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
  151.   6.10 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
  152.   6.11 SUPPLY / VALUE CHAIN: LIFE SCIENCES
  153.   6.12 LIFE SCIENCES, BY PROCEDURE TYPE, 2024 (% SHARE)
  154.   6.13 LIFE SCIENCES, BY PROCEDURE TYPE, 2024 TO 2035 (USD Billion)
  155.   6.14 LIFE SCIENCES, BY END USER, 2024 (% SHARE)
  156.   6.15 LIFE SCIENCES, BY END USER, 2024 TO 2035 (USD Billion)
  157.   6.16 LIFE SCIENCES, BY IMAGING MODALITY, 2024 (% SHARE)
  158.   6.17 LIFE SCIENCES, BY IMAGING MODALITY, 2024 TO 2035 (USD Billion)
  159.   6.18 LIFE SCIENCES, BY APPLICATION, 2024 (% SHARE)
  160.   6.19 LIFE SCIENCES, BY APPLICATION, 2024 TO 2035 (USD Billion)
  161.   6.20 BENCHMARKING OF MAJOR COMPETITORS
  162. 7 LIST OF TABLES
  163.   7.1 LIST OF ASSUMPTIONS
  164.     7.1.1
  165.   7.2 Japan MARKET SIZE ESTIMATES; FORECAST
  166.     7.2.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  167.     7.2.2 BY END USER, 2025-2035 (USD Billion)
  168.     7.2.3 BY IMAGING MODALITY, 2025-2035 (USD Billion)
  169.     7.2.4 BY APPLICATION, 2025-2035 (USD Billion)
  170.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  171.     7.3.1
  172.   7.4 ACQUISITION/PARTNERSHIP
  173.     7.4.1

Japan Life Sciences Market Segmentation

Life Sciences By Procedure Type (USD Billion, 2025-2035)

  • X-ray
  • Ultrasound
  • Magnetic Resonance Imaging
  • Computed Tomography
  • Nuclear Medicine

Life Sciences By End User (USD Billion, 2025-2035)

  • Hospitals
  • Diagnostic Centers
  • Outpatient Imaging Centers
  • Research Laboratories

Life Sciences By Imaging Modality (USD Billion, 2025-2035)

  • Analog Imaging
  • Digital Imaging
  • Hybrid Imaging

Life Sciences By Application (USD Billion, 2025-2035)

  • Cardiology
  • Oncology
  • Neurology
  • Orthopedics

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓